Navigation Links
New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
Date:5/9/2008

a(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., will market tapentadol in the United States. The NDA filing is part of the ongoing commitment of J&JPRD and PriCara(TM) to bring new and innovative products to patients and physicians for the treatment and management of pain.

Study Design

This Phase 3, double-blind, randomized, multi-center trial examined the efficacy, safety and tolerability of multiple doses of tapentadol IR in 603 post-surgical bunionectomy patients. Participants were randomly assigned (1:1:1:1:1) to receive tapentadol IR 50, 75, or 100 mg, oxycodone 15 mg, or placebo and the primary efficacy endpoint was the sum of their pain intensity differences at 48 hours. Secondary endpoints included sum of pain intensity differences at 12, 24, and 72 hours.

J&JPRD and Grunenthal GmbH supported this study.

J&JPRD and Ortho-McNeil-Janssen Pharmaceuticals, Inc. are wholly owned subsidiaries of Johnson & Johnson.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) is a wholly owned subsidiary of Johnson & Johnson, the world's most broadly based producer of health care products. J&JPRD is headquartered in Raritan, N.J., and has facilities throughout Europe, the United States and Asia. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. More information can be found at http://www.jnjpharmarnd.com/.

PriCara(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

PriCara(TM), a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is a major health care company in the United States dedicated to the needs of primary care providers who serve a vital role on the frontline of medicine. For more information about the co
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)...   DaVita HealthCare Partners Inc.  (NYSE: ... and most innovative health care communities, today announced ... Clinical Research  (DCR) and  HealthCare Partners Clinical Research , ... clinical research and data analytics services, specifically in ... renal disease (ESRD), as well as primary care ...
(Date:12/15/2014)... BOSTON , December 15, 2014 ... and development company, is pleased to announce the grant ... States relating to its GPCR-focused drug discovery ... significantly strengthens the global patent estate covering Heptares, technologies ... The suite of patents recently granted by the US ...
(Date:12/13/2014)... Dec. 11, 2014 Research and Markets ... of the "Drug Injection Devices to 2020" ... http://photos.prnewswire.com/prnh/20130307/600769 As new ... expanding list of health conditions, drug developers have ... the administration process and increase the efficiency and ...
Breaking Medicine Technology:DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... Mass., March 7, 2011 Idenix Pharmaceuticals, Inc. (Nasdaq: ... corporate overview at the Roth 23rd Annual Growth Stock Conference ... the Ritz Carlton Laguna Niguel in Dana Point, California and ... March 17, 2011 at 11:15 a.m. ET at the Loews ...
... FORT COLLINS, Colo., March 7, 2011 St. Renatus, ... to market a needle-free dental anesthetic, announced today that ... review with the U.S. Food and Drug Administration (FDA), ... will proceed with conducting Phase 3 efficacy studies to ...
Cached Medicine Technology:St. Renatus, LLC, with Guidance from the U.S. Food and Drug Administration, Has Established Readiness to Proceed to Phase 3 Trials for a New Needle-Free Dental Anesthetic 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... PatientFYI,( http://www.patientfyi.com ), an innovative, free Website that ... this week with information,and service-specific Patient Referral capabilities ... Practice Profiles. , "The ... their,strengths, and buyers make more informed decisions, in ...
... GlaxoSmithKline 12th Annual IMPACT Awards)PHILADELPHIA, Jan. 19 ... and healthcare companies, has announced the recipients of ... access to community healthcare services. Each Pennsylvania-based nonprofit ... will be held on Tuesday, March 17 at ...
... WASHINGTON, Jan. 19 The U.S. bishops urged ... that protect conscience rights of health care workers, ... ban funding of stem cell research that encourages ... a January 16 letter from Cardinal Francis George, ...
... Health Innovation Discusses the Impact of the Economic Crisis on ... A new report released today from the ... to health providers, has found that hospitals and health systems ... spending and unprofitable healthcare services as a result of the ...
... Staying fit doesn,t have to break the bank, experts say ... to make sacrifices during hard economic times, but you don,t ... Cancer Institute in Boston say people can live healthy and ... following several free and low-cost strategies. , , Get ...
... Couric told Americans that colorectal cancer (CRC) is " more ... in time . " The investigative report "Death By ... (NCI), as recently as in 2008, " ...it is not ... number of deaths from colorectal cancer. "Nonetheless, thanks to "The ...
Cached Medicine News:Health News:PatientFYI is Revolutionizing the Way Patients Find the Best Doctors to Serve Their Needs 2Health News:PatientFYI is Revolutionizing the Way Patients Find the Best Doctors to Serve Their Needs 3Health News:GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding 2Health News:GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding 3Health News:GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding 4Health News:Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research 2Health News:Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research 3Health News:Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research 4Health News:Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research 5Health News:Hospitals and Health Systems to Cut Back on Both Capital Spending and Unprofitable Services in 2009 2Health News:Hospitals and Health Systems to Cut Back on Both Capital Spending and Unprofitable Services in 2009 3Health News:Hospitals and Health Systems to Cut Back on Both Capital Spending and Unprofitable Services in 2009 4Health News:Low-Cost Strategies to Maintain Health in Hard Times 2Health News:Katie Couric Misrepresented Screening Benefits - Claims 'Death By Colonoscopy' Expose 2
... document management software that electronically captures, ... information, thus enabling immediate and reliable ... it's needed. Fortis promotes efficient knowledge ... annotating, and distribution of documents. Quickly ...
... Medical Billing proudly offers distinct medical ... area of expertise. Clinic ... codes and medical records templates for ... ob/gyn, sports medicine, ophthalmology, allergy, rheumatology, ...
... MediSoft products provide the ... physicians and billing services ... and billing, all at ... A complete MediSoft system ...
PremierEdge Stab Knives - 15....
Medicine Products: